Sio Gene Therapies Inc (SIOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2022 | 03-2021 | 03-2020 | 03-2019 | 03-2018 | |
| Operating Expenses | 71,562 | 42,197 | 69,171 | 127,018 | 213,318 |
| Operating Income | -71,562 | -42,197 | -69,171 | -127,018 | -213,318 |
| Interest Expense | 27 | 799 | 4,377 | 7,530 | 7,545 |
| Other Income | -39 | 10,359 | 1,358 | 5,616 | 211 |
| Pre-tax Income | -71,628 | -32,637 | -72,190 | -128,932 | -220,652 |
| Income Tax | 259 | -212 | 438 | 133 | 921 |
| Net Income Continuous | -71,887 | -32,425 | -72,628 | -129,065 | -221,573 |
| Net Income | $-71,887 | $-32,425 | $-72,628 | $-129,065 | $-221,573 |
| EPS Basic Total Ops | -0.98 | -0.62 | -2.93 | -8.02 | -16.51 |
| EPS Basic Continuous Ops | -0.98 | -0.62 | -2.93 | -8.02 | -16.51 |
| EPS Diluted Total Ops | -0.98 | -0.62 | -2.93 | -8.02 | -16.51 |
| EPS Diluted Continuous Ops | -0.98 | -0.62 | -2.93 | -8.02 | -16.51 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.84 | -2.93 | -8.02 | -16.48 |
| EBITDA(a) | $-70,896 | $-39,731 | $-67,694 | $-124,568 | $-210,235 |